menu
    • menu

    Company profile for Third Arc Bio

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Third Arc Bio is an advanced antibody discovery company focused on developing best-in-class T cell engagers. Our proprietary Discovery Engine integrates innovative immunization strategies, selection algorithms, and antibody engineering to identify and optimize high-potential binders. By screening thousands of binders and testing diverse architectures, including trispecifics and masking, we ensure the selection of the most prom...
    Third Arc Bio is an advanced antibody discovery company focused on developing best-in-class T cell engagers. Our proprietary Discovery Engine integrates innovative immunization strategies, selection algorithms, and antibody engineering to identify and optimize high-potential binders. By screening thousands of binders and testing diverse architectures, including trispecifics and masking, we ensure the selection of the most promising leads. With a focus on manufacturability, we streamline the transition from discovery to clinical and commercial development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Third Arc BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    888 Boylston Street, Suite 1111, Boston, MA 02199
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://thirdarcbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Third Arc Bio teams up with Adagene to create T-cell engagers
    Third Arc Bio teams up with Adagene to create T-cell engagers

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187137/0/en/Adagene-Announces-Licensing-Agreement-with-Third-Arc-Bio-for-Development-of-Two-Masked-CD3-T-Cell-Engagers-Utilizing-SAFEbody-Technology.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Third Arc Bio Begins Phase 1 Trial of ARC101 for CLDN6 Cancers
    Third Arc Bio Begins Phase 1 Trial of ARC101 for CLDN6 Cancers

    13 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/third-arc-bio-announces-first-patient-dosed-in-phase-1-clinical-trial-of-lead-t-cell-engager-arc101-to-treat-cldn6-positive-cancers-302398399.html

    PR NEWSWIRE
    13 Mar 2025
    Share Share
    J&J vets burst into biotech with $165M Third Arc series A
    J&J vets burst into biotech with $165M Third Arc series A

    23 Jul 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/jj-vets-burst-biotech-165m-third-arc-series

    FIERCE BIOTECH
    23 Jul 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search